Pfizer and BioNTech Seek Vaccine Approval for Those Ages 12-15

2021-12-17 1

A successful Phase 3 clinical trial has led to the Pfizer and BioNTech to seek full vaccine approval for people between 12 and 15 years-old. Veuer’s Maria Mercedes Galuppo has the story.

Free Traffic Exchange